Facebook Share Google Plus Share Twitter Share LinkedIn Share Pinterest Share StumbleUpon Share Reddit Share E-Mail Share

  • IP Server: (See full)
  • Location: United Kingdom (See map)
  • Registed: Unknown
  • Ping: 72 ms
  • HostName:
  • DNS Server:,

Websites Hosted on

Tools Checker

  • Hostname:
  • Country: United Kingdom
  • Latitude: 51.496398925781
  • Longitude: -0.12240000069141
  • Area Code: 0
  • Email Abuse: No Emails

Port Scanner (IP:

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080

Top Keywords Suggestions

  › Etransafe
  › Etransfer
  › Etransfer logo
  › E transfer to canada
  › Etransfer mt
  › Etransfer ca
  › Etransfer ny
  › Etransfer usa

Top 10 related websites

eTRANSAFE – Enhancing TRANslational SAFEty Assessment

(9 days ago) The etransafe (enhancing translational safety assessment through integrative knowledge management) project works to improve the efficiency of translational safety assessment approaches during the medicines discovery pipeline

DA: 12 PA: 12 MOZ Rank: 13


Structure – eTRANSAFE

(6 days ago) The work plan of the etransafe project has been designed to support the overall objectives of the project. work packages 1, 2 and 10 are overarching wps dealing respectively with scientific coordination and management (wp1), overarching policies and liaison with regulators (wp2), and sustainability, communication and outreach (wp10).

DA: 12 PA: 11 MOZ Rank: 23



(1 months ago) The etransafe project is funded by the innovative medicines initiative (imi), a large-scale public-private partnership between the european union and the pharmaceutical industry association efpia.. imi aims to boost biopharmaceutical innovation in europe and to speed up the development of better and safer medicines for patients. through its unique and innovative funding scheme, imi supports

DA: 12 PA: 11 MOZ Rank: 23



(1 months ago) Email address: leave this field empty if you're human:

DA: 12 PA: 5 MOZ Rank: 17


Partners – eTRANSAFE

(18 days ago) The etransafe consortium brings together 27 organisations that mobilise an unprecedented capacity and resources and that are uniquely placed to leverage the experience of etox and other relevant eu projects and networks. the project partners are eight prestigious academic institutions, six highly skilled small-medium enterprises (sme), twelve pharmaceutical companies and one partner in research.

DA: 12 PA: 20 MOZ Rank: 32


Info Request - Lhasa Limited

(7 days ago) Complete this form to request further information on one of lhasa's products or initiatives or just for general information about lhasa.

DA: 20 PA: 30 MOZ Rank: 50


eTRANSAFE | IMI Innovative Medicines Initiative

(8 days ago) . twitter: @etransafe. this project is funded by the innovative medicines initiative, a public-private partnership between the european union and the european federation of pharmaceutical industries and associations (efpia) about imi. objectives;

DA: 17 PA: 46 MOZ Rank: 63


eTRANSAFE Project (@etransafe) | Twitter

(1 year ago) The latest tweets from etransafe project (@etransafe). etransafe aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the security in drug development

DA: 11 PA: 10 MOZ Rank: 21



(1 months ago) The enhancing translational safety assessment through integrative knowledge management (etransafe) project will develop an integrated data infrastructure and innovative computational methods and tools to drastically improve the feasibility and reliability of translational safety assessment during the drug development process.

DA: 20 PA: 26 MOZ Rank: 46


About Us - Lhasa Limited

(5 days ago) About us what we do we accelerate discovery within the life sciences. we accelerate the discovery pipeline of the life sciences industry by enabling scientifically robust decisions to be made faster through advanced analytics which are informed by our position as the industry’s honest broker.

DA: 20 PA: 13 MOZ Rank: 33


Recently Analyzed (0 seconds ago) / US (0 seconds ago) / US (0 seconds ago) / JP (0 seconds ago) / US (0 seconds ago) / US (0 seconds ago) / FR (1 seconds ago) / GB (1 seconds ago) / US (2 seconds ago) / US (2 seconds ago) / US (2 seconds ago) / AT (2 seconds ago) / US